Pandora Wealth, Inc. Synthetic Biologics, Inc. Transaction History
Pandora Wealth, Inc.
- $152 Billion
- Q1 2025
A detailed history of Pandora Wealth, Inc. transactions in Synthetic Biologics, Inc. stock. As of the latest transaction made, Pandora Wealth, Inc. holds 4 shares of SYN stock, worth $2. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4Holding current value
$2% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SYN
# of Institutions
1Shares Held
4Call Options Held
0Put Options Held
0About Synthetic Biologics, Inc.
- Ticker SYN
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,844,100
- Market Cap $9.51M
- Description
- Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...